SMTL ID : 3oyw.1

Crystal structure of human galectin-1 in complex with thiodigalactoside

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

homo-dimer

Ligands

2 x YIO- GAL: beta-D-galactopyranose-(1-1)-1-thio-beta-D-galactopyranose(Non-covalent)

YIO-GAL.1: 8 residues within 4Å: Chain A: H.44, N.46, R.48, H.52, N.61, W.68, E.71, R.73 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:R.48, A:R.48, A:E.71, A:R.73, A:R.48, A:H.52, A:N.61, A:E.71 Water bridges: A:E.71, A:N.46, A:N.46 YIO-GAL.2: 8 residues within 4Å: Chain B: H.44, N.46, R.48, H.52, N.61, W.68, E.71, R.73 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:R.48, B:R.48, B:E.71, B:R.73, B:R.48, B:H.52, B:N.61, B:E.71 Water bridges: B:N.46

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Stannard, K.A. et al., Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. CANCER LETT. (2010)

Release Date

2010-11-03

Peptides

Galectin-1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Galectin-1

Related Entries With Identical Sequence